Purple Biotech Corp (PPBT): Balans kapitallashuviga qarzlar

Purple Biotech Ltd (PPBT) grafik logotipi

CM24 antitelosi orqali o'simta qarshiligiga qarshi kurashish ekotizimining yaratilishi Purple Biotech (PPBT) uchun tadqiqotlar poydevorini yaratdi. Qarzning kitob qiymatidagi kapitalizatsiya ko'rsatkichi dinamikasi ushbu jarayonni vizuallashtiradi, bunda joriy holat 0.01 ga tengdir. Robotlashtirilgan dori vositalarini skrining qilishning joriy etilishi terapiya izlashni tezlashtirdi, rejalashtirilgan inhibitorlarni ishlab chiqish uchun rezervlardan foydalanish esa yangi qarzlar yo'qligida moliyaviy barqarorlikni ta'minladi.

Purple Biotech (PPBT) - Balans qiymatiga qarzlar 04.07.2022dan 27.10.2026gacha

Purple Biotech Ltd (PPBT) kompaniyasi koʻrsatkichlari kesimi va tahlili

- narx va narxlar bo'yicha konsensus prognoz:
Narx grafigi Purple Biotech|PPBT - Investitsiya uylarining umumiy prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi Kitov Pharma|PPBT - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati Purple Biotech|PPBT - Kompaniyaning xususiy kapitali|Bozor qiymatining balans qiymatiga nisbati purple-biotech.com|PPBT - Aktivlarning umumiy qiymati
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning xususiy kapitalga nisbati Purple Biotech|PPBT - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning kapitalga nisbati Purple Biotech Corp|PPBT - Kompaniyaning umumiy qarzi|Qarzning balans qiymatiga nisbati Kitov Pharma
Kompaniyaning barcha koʻrsatkichlari tahlili:Purple Biotech PPBT
Purple Biotech Ltd asosiy tovari

Purple Biotech (PPBT) uchun moliyaviy barqarorlik qimmatga tushadigan klinik sinovlarni yakunlash qobiliyatini bevosita belgilaydi. Balans hisoboti kapital tuzilmasiga nisbatan qarz majburiyatlarida aks etgan umumiy qarz va kapital nisbati kreditorlarga bo'lgan bog'liqlik darajasini o'lchaydi. Ushbu ko'rsatkich qarz leverajining moliyaviy avtonomiya bilan muvozanatini ifodalaydi. Sog'liqni saqlash giganti uchun likvidlikni saqlash onkologik dori vositalari bo'yicha so'nggi bosqich tadqiqotlarini o'tkazish uchun juda muhimdir. Haddan tashqari ko'p qarz terapiyaning selektivligi tasdiqlangandan keyin kengayish imkoniyatlarini cheklashi mumkin.

Purple Biotech kimlar bilan raqobatlashadi

ONC - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati halozyme.com HALO|RVMD: Balans kapitallashuviga qarzlar|AAPG - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar CGON|URGN (UroGen Pharma Corp) - Balans qiymatiga qarzlar|BCAX - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati personalis.com (PSNL)|Erasca (ERAS) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati Delcath Systems Inc (DCTH)|YmAbs - Balans kapitallashuviga qarzlar|AURA - Qarzning balans qiymatiga nisbati|Candel - Qarzning balans qiymatiga nisbati|ARAY: Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati sellaslifesciences.com SLS|Actuate Therapeutics Inc. (ACTU) - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar CTOR (Citius Oncology, Inc)|Balans qiymatiga qarzlar HURA|TARA - Qarzning balans kapitallashuviga nisbati|Qarzlarning balans kapitallashuviga nisbati fatetherapeutics.com FATE|Qarzning balans qiymatiga nisbati WHWK (Aadi Bioscience)|TScan Therapeutics Inc - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Champions Oncology Corp (CSBR)|XBIT: Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati cel-sci.com (CVM)|OSTX (ostherapies.com) - Qarzlarning balans kapitallashuviga nisbati|Qarzning balans kapitallashuviga nisbati Radiopharm Theranostics Limited|Qarzning balans kapitallashuviga nisbati Artiva|Adlai Nortye Ltd. - Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar Veru Corporation VERU|Qarzning balans qiymatiga nisbati Tempest Therapeutics|Qarzning sof aktivlarga nisbati Xilio Therapeutics Inc XLO|RENB - Balans kapitallashuviga qarzlar|MURA - Qarzning balans kapitallashuviga nisbati|kairospharma.com - Balans kapitallashuviga qarzlar|OKUR (OnKure Therapeutics) - Sof aktivlarga qarzlar|Qarzning balans kapitallashuviga nisbati GDTC (CytoMed Therapeutics Ltd)|Balans qiymatiga qarzlar Curis Corp (CRIS)|Qarzning balans qiymatiga nisbati Apollomics, Inc.|Qarzning balans kapitaliga nisbati Tharimmune Inc (THAR)|ADVB: Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar Genprex Inc GNPX|CLDI: Balans kapitallashuviga qarzlar|SBFM - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar xeneticbio.com XBIO|SLRX (Salarius Pharmaceuticals Inc) - Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati American Oncology Network Inc AONC|Qarzlarning balans kapitallashuviga nisbati BGNE|CKPT - Qarzning balans kapitallashuviga nisbati|Qarzlarning balans kapitallashuviga nisbati elevationoncology.com (ELEV)|Balans kapitallashuviga qarzlar iCAD ICAD|IKNA - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati Notable Labs Inc. NTBL|VIRX - Qarzning balans kapitaliga nisbati|MOR (MorphoSys AG) - Balans kapitallashuviga qarzlar|nayabiosciences.com (NAYA) - Qarzning balans qiymatiga nisbati|AAPGV (Ascentage Pharma) - Balans kapitallashuviga qarzlar